Dawn Christine Maroney Sells 30,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 30,000 shares of the business’s stock in a transaction on Wednesday, May 14th. The stock was sold at an average price of $14.87, for a total transaction of $446,100.00. Following the completion of the transaction, the president now owns 2,102,899 shares of the company’s stock, valued at approximately $31,270,108.13. This trade represents a 1.41% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Dawn Christine Maroney also recently made the following trade(s):

• On Monday, April 14th, Dawn Christine Maroney sold 230,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $19.10, for a total transaction of $4,393,000.00.
• On Thursday, March 27th, Dawn Christine Maroney sold 11,152 shares of Alignment Healthcare stock. The stock was sold at an average price of $17.89, for a total transaction of $199,509.28.
• On Wednesday, March 19th, Dawn Christine Maroney sold 16,535 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.40, for a total transaction of $271,174.00.
• On Monday, March 17th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.99, for a total transaction of $479,700.00.
• On Wednesday, March 12th, Dawn Christine Maroney sold 27,243 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total transaction of $420,359.49.
• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00.

Alignment Healthcare Trading Down 0.1%

NASDAQ ALHC opened at $14.90 on Friday. The stock has a market capitalization of $2.95 billion, a P/E ratio of -19.35 and a beta of 1.32. Alignment Healthcare, Inc. has a 52-week low of $6.82 and a 52-week high of $21.06. The firm has a 50-day moving average price of $17.30 and a 200 day moving average price of $14.53. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.07. Alignment Healthcare had a negative net margin of 5.84% and a negative return on equity of 108.69%. The company had revenue of $926.93 million for the quarter, compared to analyst estimates of $889.83 million. During the same period in the prior year, the business posted ($0.25) earnings per share. The firm’s revenue for the quarter was up 47.5% compared to the same quarter last year. Equities research analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the stock. Stifel Nicolaus upped their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a “buy” rating in a research note on Tuesday, April 8th. Barclays upped their target price on shares of Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. Bank of America upped their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a report on Tuesday, March 4th. JPMorgan Chase & Co. upped their target price on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a report on Thursday, March 6th. Finally, William Blair reaffirmed an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Alignment Healthcare has a consensus rating of “Moderate Buy” and an average price target of $17.17.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ALHC. Wellington Management Group LLP grew its position in Alignment Healthcare by 77.9% during the fourth quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after buying an additional 3,257,630 shares during the period. T. Rowe Price Investment Management Inc. grew its position in shares of Alignment Healthcare by 54.7% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock valued at $97,302,000 after purchasing an additional 3,059,596 shares during the last quarter. Millennium Management LLC grew its position in shares of Alignment Healthcare by 588.3% in the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock valued at $38,122,000 after purchasing an additional 2,896,311 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Alignment Healthcare in the fourth quarter valued at approximately $20,087,000. Finally, Invesco Ltd. grew its position in shares of Alignment Healthcare by 1,415.7% in the first quarter. Invesco Ltd. now owns 1,875,790 shares of the company’s stock valued at $34,927,000 after purchasing an additional 1,752,033 shares during the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.